Search research articles
Contact Us
Filters
Showing results (871-880 of 1,146) with videos related to
Page
of 115
Sort By:
Molecular Neurobiology
|
March 8, 2014
Loss of prion protein leads to age-dependent behavioral abnormalities and changes in cytoskeletal protein expression
Matthias Schmitz, Catharina Greis, Philipp Ottis, et al.
BMC Neurology
|
September 23, 2006
Brain-derived proteins in the CSF: do they correlate with brain pathology in CJD?
Constanze Boesenberg-Grosse, Walter J Schulz-Schaeffer, Monika Bodemer, et al.
European Journal of Neurology
|
August 8, 2008
MRI in the classical MM1 and the atypical MV2 subtypes of sporadic CJD: an inter-observer agreement study
A Krasnianski, K Kallenberg, D A Collie, et al.
Frontiers in Endocrinology
|
February 11, 2020
Standardised Nomenclature, Abbreviations, and Units for the Study of Bone Marrow Adiposity: Report of the Nomenclature Working Group of the International Bone Marrow Adiposity Society
Nathalie Bravenboer, Miriam A Bredella, Christophe Chauveau, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology
|
August 2, 2011
Activation of the aryl hydrocarbon receptor suppresses sensitization in a mouse peanut allergy model
V J Schulz, J J Smit, K J Willemsen, et al.
Journal of Neurology
|
January 23, 2009
MRI and clinical syndrome in dura mater-related Creutzfeldt-Jakob disease
B Meissner, K Kallenberg, P Sanchez-Juan, et al.
Research (Washington, D.C.)
|
May 15, 2026
Artificial Intelligence Decodes Brain Elemental Signatures to Stratify Aging and Neurological Diseases
Augustin Tillement, Eszter Nemeth, Laurent David, et al.
Bioorganic & Medicinal Chemistry Letters
|
October 16, 2004
Parallel methods for the preparation and SAR exploration of N-ethyl-4-[(8-alkyl-8-aza-bicyclo[3.2.1]oct-3-ylidene)-aryl-methyl]-benzamides, powerful mu and delta opioid agonists
Steven J Coats, Mark J Schulz, John R Carson, et al.
Bioorganic & Medicinal Chemistry Letters
|
April 21, 2009
Triazinediones as prokineticin 1 receptor antagonists. Part 1: SAR, synthesis and biological evaluation
Janet L Ralbovsky, Joseph G Lisko, Jeffrey M Palmer, et al.
Molecular Biology and Evolution
|
November 3, 2022
Allele-specific Expression Reveals Multiple Paths to Highland Adaptation in Maize
Haixiao Hu, Taylor Crow, Saghi Nojoomi, et al.
Page
of 115
Search research articles
Search
Showing results (871-880 of 1,146) with videos related to
Sort By:
Page
of 115
Molecular Neurobiology
|
March 8, 2014
Loss of prion protein leads to age-dependent behavioral abnormalities and changes in cytoskeletal protein expression
Matthias Schmitz, Catharina Greis, Philipp Ottis, et al.
BMC Neurology
|
September 23, 2006
Brain-derived proteins in the CSF: do they correlate with brain pathology in CJD?
Constanze Boesenberg-Grosse, Walter J Schulz-Schaeffer, Monika Bodemer, et al.
European Journal of Neurology
|
August 8, 2008
MRI in the classical MM1 and the atypical MV2 subtypes of sporadic CJD: an inter-observer agreement study
A Krasnianski, K Kallenberg, D A Collie, et al.
Frontiers in Endocrinology
|
February 11, 2020
Standardised Nomenclature, Abbreviations, and Units for the Study of Bone Marrow Adiposity: Report of the Nomenclature Working Group of the International Bone Marrow Adiposity Society
Nathalie Bravenboer, Miriam A Bredella, Christophe Chauveau, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology
|
August 2, 2011
Activation of the aryl hydrocarbon receptor suppresses sensitization in a mouse peanut allergy model
V J Schulz, J J Smit, K J Willemsen, et al.
Journal of Neurology
|
January 23, 2009
MRI and clinical syndrome in dura mater-related Creutzfeldt-Jakob disease
B Meissner, K Kallenberg, P Sanchez-Juan, et al.
Research (Washington, D.C.)
|
May 15, 2026
Artificial Intelligence Decodes Brain Elemental Signatures to Stratify Aging and Neurological Diseases
Augustin Tillement, Eszter Nemeth, Laurent David, et al.
Bioorganic & Medicinal Chemistry Letters
|
October 16, 2004
Parallel methods for the preparation and SAR exploration of N-ethyl-4-[(8-alkyl-8-aza-bicyclo[3.2.1]oct-3-ylidene)-aryl-methyl]-benzamides, powerful mu and delta opioid agonists
Steven J Coats, Mark J Schulz, John R Carson, et al.
Bioorganic & Medicinal Chemistry Letters
|
April 21, 2009
Triazinediones as prokineticin 1 receptor antagonists. Part 1: SAR, synthesis and biological evaluation
Janet L Ralbovsky, Joseph G Lisko, Jeffrey M Palmer, et al.
Molecular Biology and Evolution
|
November 3, 2022
Allele-specific Expression Reveals Multiple Paths to Highland Adaptation in Maize
Haixiao Hu, Taylor Crow, Saghi Nojoomi, et al.
Page
of 115